Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches

Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches

Abstract Cancer is a leading cause of death which imposes a substantial financial burden. Among the several mechanisms involved in cancer progression, imbalance of immune cell‐derived factors such as cytokines and chemokines plays a central role. IL‐25, as a member of the IL‐17 cytokine subfamily, e...

Full description

Bibliographic Details
Main Authors: Arezoo Gowhari Shabgah, Azwar Amir, Zhanna R. Gardanova, Angelina Olegovna Zekiy, Lakshmi Thangavelu, Maryam Ebrahimi Nik, Majid Ahmadi, Jamshid Gholizadeh Navashenaq
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Cancer Medicine
Subjects:
biomarker
Cancer
cytokine
IL‐17E
IL‐25
Online Access:https://doi.org/10.1002/cam4.4060

Similar Items

Similar Items